Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

Meng-Jer Hsieh,1 Ning-Hung Chen,2 Shih-Lung Cheng,3,4 Chi-Wei Tao,5 Yu-Feng Wei,6,7 Yao-Kuang Wu,8 Ming-Cheng Chan,9,10 Shih-Feng Liu,11– 13 Wu-Huei Hsu,14 Tsung-Ming Yang,15 Ming-Shian Lin,16,17 Ching-Lung Liu,18 Ping-Hung Kuo,19 Ying-Huang Tsai1,20 1Department of Pulmonary and Critical Care Medici...

Full description

Bibliographic Details
Main Authors: Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, Lin MS, Liu CL, Kuo PH, Tsai YH
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:International Journal of COPD
Subjects:
tiotropium/olodaterol
laba/lama therapy
taiwan
cohort study
propensity score matching
chronic obstructive pulmonary disease
moderate-to-severe exacerbation
Online Access:https://www.dovepress.com/comparing-clinical-outcomes-of-tiotropiumolodaterol-umeclidiniumvilant-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/comparing-clinical-outcomes-of-tiotropiumolodaterol-umeclidiniumvilant-peer-reviewed-fulltext-article-COPD

Similar Items